nach oben

Erschienen in:

2016 | OriginalPaper | Buchkapitel

2. Alternative Verfahren beim Nierenzellkarzinom

verfasst von : Dr. med. B. Friebe, Dr. med. T. Bretschneider, Prof. Dr. med. J. Ricke, Priv.-Doz. Dr. med. habil. U.-B. Liehr, Dr. med. J. J. Wendler, Prof. Dr. med. H. C. Klingler, Prof. Dr. med. M. Susani, Dr. med. S. Sevcenco

Erschienen in: Alternative operative Therapien in der Uroonkologie

Verlag: Springer Berlin Heidelberg

Einloggen, um Zugang zu erhalten

Zusammenfassung

Durch die fast flächendeckende Anwendung bildgebender Diagnostik wie Ultraschall, Magnetresonanz- oder Computertomographie wird eine zunehmende Anzahl von Nierentumoren in einem frühen, lokal begrenzten, oft symptomlosen Stadium diagnostiziert. Aus bisherigen Beobachtungsstudien weiß man, dass diese kleinen, inzidenten Nierentumoren einerseits zwar in bis zu 87 % der Fälle maligne sind, andererseits jedoch meist nur sehr langsam wachsen und sehr selten metastasieren, weswegen auch diese Tumoren zunehmend nierenerhaltend operiert werden. Als Alternative stehen die folgenden bildgestützten, lokalablativen Verfahren zur Verfügung: Radiofrequenzablation, Kryoablation, bildgeführte interstitielle Hochdosisratenbrachytherapie sowie die Mikrowellenablation, die Laserablation und die Ablation durch hochintensiven, fokussierten Ultraschall. Alle Techniken sind entweder minimalinvasiv perkutan oder laparoskopisch anwendbar und weisen niedrigere Komplikationsraten als die Nierenteilresektion auf.

Arima K, Yamakado K, Kinbara H et al. (2007) Percutaneous radiofrequency ablation with transarterial embolization is useful for treatment of stage 1 renal cell carcinoma with surgical risk: results at 2-year mean follow up. Int J Urol 14:585-590; discussion 590PubMedCrossRef

Atwell TD, Schmit GD, Boorjian SA et al. (2013) Percutaneous ablation of renal masses measuring 3.0 cm and smaller: comparative local control and complications after radiofrequency ablation and cryoablation. AJR Am J Roentgenol 200:461–466PubMedCrossRef

Bosniak MA (1995) Observation of small incidentally detected renal masses. Semin Urol Oncol 13:267–272PubMed

Bosniak MA, Birnbaum BA, Krinsky GA et al. (1995) Small renal parenchymal neoplasms: further observations on growth. Radiology 197:589–597PubMedCrossRef

Bosniak MA, Krinsky GA, Waisman J (1995) Management of small incidental renal parenchymal tumors by watchful-waiting in selected patients based on observations of tumor growth rates. J Urol 1995:584–A

Campbell SC, Novick AC, Belldegrun A et al. (2009) Guideline for management of the clinical T1 renal mass. J Urol 182:1271–1279PubMedCrossRef

Chang EL, Selek U, Hassenbusch SJ 3rd et al. (2005) Outcome Variation among »radioresistant« brain metastases treated with stereotactic radiosurgery. Neurosurgery 56:936-945; discussion 936–945PubMedCrossRef

Collettini F, Singh A, Schnapauff D, Powerski MJ, Denecke T, Wust P, Hamm B, Gebauer B (2013) Computed-tomography-guided high-dose-rate brachytherapy (CT-HDRBT) ablation of metastases adjacent to the liver hilum. Eur J Radiol 82(10):e509–514. doi: 10.1016/j.ejrad.2013.04.046. Epub 2013 Jun 21CrossRef

Deschavanne PJ, Fertil B (1996) A review of human cell radiosensitivity in vitro. Int J Radiat Oncol Biol Phys 34:251-266

DiBiase SJ, Valicenti RK, Schultz D et al. (1997) Palliative irradiation for focally symptomatic metastatic renal cell carcinoma: support for dose escalation based on a biological model. J Urol 158:746–749

Dindo D, Demartines N, Clavien PA (2004) Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 240:205–213PubMedPubMedCentralCrossRef

Frank I, Blute ML, Cheville JC et al. (2003) Solid renal tumors: an analysis of pathological features related to tumor size. J Urol 170:2217–2220PubMedCrossRef

Halperin EC, Harisiadis L (1983) The role of radiation therapy in the management of metastatic renal cell carcinoma. Cancer 51:614–617PubMedCrossRef

Henschke UK, Hilaris BS, Mahan GD (1964) Remote after-loading with intracavitary applicators. Radiology 83: 344–345PubMedCrossRef

Kunkle DA, Egleston BL, Uzzo RG (2008) Excise, ablate or observe: the small renal mass dilemma - a meta-analysis and review. J Urol 179:1227-1233; discussion 1233–1224

Lee J, Hodgson D, Chow E et al. (2005) A phase II trial of palliative radiotherapy for metastatic renal cell carcinoma. Cancer 104:1894–1900PubMedCrossRef

Ljungberg B, Cowan NC, Hanbury, DC et al. (2010) EAU guide-lines on renal cell carcinoma: the 2010 update. Eur Urol 58:398–406PubMedCrossRef

Lounsberry W, Goldschmidt V, Linke CA et al. (1961) The early histologic changes following electrocoagulation. J Urol 86:321–329PubMed

Nakasone Y, Kawanaka K, Ikeda O et al. (2012) Sequential combination treatment (arterial embolization and percutaneous radiofrequency ablation) of inoperable renal cell carcinoma: single-center pilot study. Acta Radiol 53:410–414PubMedCrossRef

National Cancer Institute (NCI) (2009). Common Terminology Criteria for Adverse Events v4.0. NCI, NIH, DHHS. May 29, 2009. NIH publication # 09-7473

Onufrey V, Mohiuddin M (1985) Radiation therapy in the treatment of metastatic renal cell carcinoma. Int J Radiat Oncol Biol Phys 11:2007–2009

Orton CG, Ellis F (1973) A simplification in the use of the NSD concept in practical radiotherapy. Br J Radiol 46:529–537PubMedCrossRef

Park S, Strup SE, Saboorian H et al. (2006) No evidence of disease after radiofrequency ablation in delayed nephrectomy specimens. Urology 68:964–967PubMedCrossRef

Psutka SP, Feldman AS, McDougal WS et al. (2013) Long-term oncologic outcomes after radiofrequency ablation for T1 renal cell carcinoma. Eur Urol 63:486–492PubMedCrossRef

Rais-Bahrami S, Guzzo TJ, Jarrett TW et al. (2009) Incidentally discovered renal masses: oncological and perioperative outcomes in patients with delayed surgical intervention. BJU Int 103:1355–1358PubMedCrossRef

Remzi M, Marberger M (2009) Renal tumor biopsies for evaluation of small renal tumors: why, in whom, and how? Eur Urol 55:359–367PubMedCrossRef

Rendon RA, Kachura JR, Sweet JM et al. (2002) The uncertainty of radio frequency treatment of renal cell carcinoma: findings at immediate and delayed nephrectomy. J Urol 167:1587–1592PubMedCrossRef

Ricke J, Mohnike K, Pech M et al. (2010) Local response and impact on survival after local ablation of liver metastases from colorectal carcinoma by computed tomography-guided high-dose-rate brachytherapy. Int J Radiat Oncol Biol Phys 78:479–485PubMedCrossRef

Shannon BA, Cohen RJ, de Bruto H et al. (2008) The value of preoperative needle core biopsy for diagnosing benign lesions among small, incidentally detected renal masses. J Urol 180:1257-1261; discussion 1261

Simmons MN, Weight CJ, Gill IS (2009) Laparoscopic radical versus partial nephrectomy for tumors 4 cm: intermediate-term oncologic and functional outcomes. Urology 73:1077–1082PubMedCrossRef

Stinauer MA, Kavanagh BD, Schefter TE et al. (2011) Stereotactic body radiation therapy for melanoma and renal cell carcinoma: impact of single fraction equivalent dose on local control. Radiat Oncol 6:3–4CrossRef

Svedman C, Sandstrom P, Pisa P et al. (2006) A prospective phase II trial of using extracranial stereotactic radiotherapy in primary and metastatic renal cell carcinoma. Acta Oncol 45:870–875PubMedCrossRef

Takaki H, Nakatsuka A, Uraki J et al. (2013) Renal cell carcinoma: radiofrequency ablation with a multiple-electrode switching system - a phase II clinical study. Radiology 267:285–292PubMedCrossRef

Takaki H, Soga N, Kanda H et al. (2014) Radiofrequency ablation versus radical nephrectomy: clinical outcomes for stage T1b renal cell carcinoma. Radiology 270: 292–299PubMedCrossRef

Teh B, Bloch C, Galli-Guevara M et al. (2007) The treatment of primary and metastatic renal cell carcinoma (RCC) with image-guided stereotactic body radiation therapy (SBRT). Biomed Imaging Interv J 3:e–6

Thompson RH, Atwell T, Schmit G et al. (2015) Comparison of Partial Nephrectomy and Percutaneous Ablation for cT1 Renal Masses. Eur Urol 67(2):252–259PubMedCrossRef

Tselis N, Chatzikonstantinou G, Kolotas C, Milickovic N, Baltas D, Zamboglou N (2013) Computed tomography-guided interstitial high dose rate brachytherapy for centrally located liver tumours: a single institution study. Eur Radiol 23(8):2264–2270. doi: 10.1007/s00330-013-2816-z. Epub 2013 Mar 21PubMedCrossRef

Van Poppel H, Da Pozzo, Albrecht W et al. (2007) A prospective randomized EORTC intergroup phase 3 study comparing the complications of elective nephron-sparing surgery and radical nephrectomy for low-stage renal cell carcinoma. Eur Urol 51:1606–1615PubMedCrossRef

Wagstaff P, Ingels A, Zondervan P et al. (2014) Thermal ablation in renal cell carcinoma management: a comprehensive review. Curr Opin Urol 24:474–482PubMedCrossRef

Wah TM, Irving HC, Gregory W et al. Radiofrequency ablation (RFA) of renal cell carcinoma (RCC): experience in 200 tumours. BJU Int 2014;113:416-428

Wannenmacher M, Wenz F, Debus J (2013) Strahlentherapie. Springer, HeidelbergCrossRef

Weight CJ, Kaouk JH, Hegarty NJ et al. (2008) Correlation of radiographic imaging and histopathology following cryoablation and radio frequency ablation for renal tumors. J Urol 179:1277-1281; discussion 1281–1273CrossRef

Wieners G, Pech M, Rudzinska M et al. (2006) CT-guided interstitial brachytherapy in the local treatment of extrahepatic, extrapulmonary secondary malignancies. Eur Radiol 16:2586–2593PubMedCrossRef

Wieners G, Mohnike K, Peters N, Bischoff J, Kleine-Tebbe A, Seidensticker R, Seidensticker M, Gademann G, Wust P, Pech M, Ricke J (2011) Treatment of hepatic metastases of breast cancer with CT-guided interstitial brachytherapy-a phase II-study. Radiother Oncol 100(2):314–319. doi:10.1016/j.radonc.2011.03.005. Epub 2011 Apr 16PubMedCrossRef

Yamakado K, Nakatsuka A, Kobayashi S et al. (2006) Radiofrequency ablation combined with renal arterial embolization for the treatment of unresectable renal cell carcinoma larger than 3.5 cm: initial experience. Cardiovasc Intervent Radiol 29:389–394PubMedCrossRef

Ball C, Thomson KR, Kavnoudias H (2010) Irreversible electroporation: a new challenge in »out of operating theater« anesthesia. Anesthesia & Analgesia 110:1305–1309CrossRef

van den Bos W, de Bruin DM, Muller BG, Varkarakis IM, Karagiannis AA, Zondervan PJ, Laguna Pes MP, Veelo DP, Savci Heijink CD, Engelbrecht MR, Wijkstra H, de Reijke TM, de la Rosette JJ (2014) The safety and efficacy of irreversible electroporation for the ablation of prostate cancer: a multicentre prospective human in vivo pilot study protocol. BMJ Open 4(10):e006382. ClinicalTrials. gov database NCT01790451. https://clinicaltrials.gov/ct2/show/NCT01790451?term=NCT01790451&rank=1 . Zugegriffen: 25. März 2015

Davalos RV, Mir IL, Rubinsky B (2005) Tissue ablation with irreversible electroporation. Ann Biomed Eng 33(2):223–231PubMedCrossRef

Deodhar A, Monette S, Single GW Jr, Hamilton WC Jr, Thornton R, Maybody M, Coleman JA, Solomon SB (2011) Renal tissue ablation with irreversible electroporation: preliminary results in a porcine model. Urology 77(3): 754–760PubMedCrossRef

Faroja M, Ahmed M, Appelbaum L, Ben-David E, Moussa M, Sosna J, Nissenbaum I, Goldberg SN (2013) Irreversible electroporation ablation: is all the damage nonthermal? Radiology 266(2):462–470PubMedCrossRef

Fornara P, Doehn C, Friedrich HJ, Jocham D (2001) Nonrandomized comparison of open flank versus laparoscopic nephrectomy in 249 patients with benign renal disease. Eur Urol 40(1):24–31PubMedCrossRef

Gunn AJ, Gervais DA (2014) Percutaneous ablation of the small renal mass-techniques and outcomes. Semin Intervent Radiol 31(1):33–41PubMedPubMedCentralCrossRef

Ladd AP, Rescorla FJ, Baust JG, Callahan M, Davis M, Grosfeld JL (1999) Cryosurgical effects on growing vessels. Am Surg 65(7):677–682PubMed

Lee EW, Wong D, Prikhodko SV, Perez A, Tran C, Loh CT, Kee ST (2012) Electron microscopic demonstration and evaluation of irreversible electroporation-induced nanopores on hepatocyte membranes. J Vasc Interv Radiol 23(1):107–113

Liehr UB, Wendler JJ, Blaschke S, Porsch M, Janitzky A, Baumunk D, Pech M, Fischbach F, Schindele D, Grube C, Ricke J, Schostak M (2012) Irreversible electroporation: the new generation of local ablation techniques for renal cell carcinoma. Urologe A 51(12):1728–1734

Ljungberg B, Cowan N, Hanbury DC, Hora M, Kuczyk MA, Merseburger AS, Mulders PFA, Patard JJ, Sinescu IC, European Association of Urology Group (2010) EAU guidelines on renal cell carcinoma: the 2010 update. Eur Urol 58(3):398–406PubMedCrossRef

Ljungberg B, Bensalah K, Bex A, Canfield S, Dabestani S, Hofmann F, Hora M, Kuczyk MA, Lam T, Marconi L, Merseburger AS, Mulders PFA, Powles T, Staehler M, Volpe A, Bex A (2015) EAU guidelines on renal cell carcinoma: 2014 update. Eur Urol. 2015 Jan 20. doi: 10.1016/j. eururo.2015.01.005

Lu DS, Raman SS, Vodopich DJ, Wang M, Sayre J, Lassman C (2002) Effect of vessel size on creation of hepatic radiofrequency lesions in pigs: assessment of the »heat sink« effect. AJR Am J Roentgenol 178(1):47–51PubMedCrossRef

MacLennan S, Imamura M, Lapitan MC, Omar MI, Lam TB, Hilvano-Cabungcal AM, Royle P, Stewart F, MacLennan G, MacLennan SJ, Canfield SE, McClinton S, Griffiths TR, Ljungberg B, N'Dow J; UCAN Systematic Review Reference Group; EAU Renal Cancer Guideline Panel (2012) Systematic review of oncological outcomes following surgical management of localised renal cancer. Eur Urol 61(5):972–993CrossRef

Neumann E, Schaeffer-Ridder M, Wang Y, Hofschneider PH (1982) Gene transfer into mouse lymphoma cells by electroporation in high electric fields. EMBO J 1: 841–845PubMedPubMedCentral

The National Institute for Health and Clinical Excellence (NICE) (2013) NICE-Guideline: irreversible electroporation for the treatment of renal cancer, S 1-22. http://www.nice.org.uk/guidance/IPG443 . Zugegriffen: 23. März 2015

Olweny EO, Kapur P, Tan YK, Park SK, Adibi M, Cadeddu JA (2013) Irreversible electroporation: evaluation of nonthermal and thermal ablative capabilities in the porcine kidney. Urology 81(3):679–684PubMedCrossRef

Pech M, Janitzky A, Wendler JJ et al. (2011) Irreversible electroporation of renal cell carcinoma: a first-in-man phase I clinical study. Cardiovasc Intervent Radiol 34:132–138PubMedCrossRef

Wendler JJ, Porsch M, Nitschke S, Köllermann J, Siedentopf S, Pech M, Fischbach F, Ricke J, Schostak M, Liehr UB (2015) A prospective phase 2a pilot study investigating focal percutaneous irreversible electroporation (IRE) ablation by NanoKnife in patients with localised renal cell carcinoma (RCC) with delayed interval tumour resection (IRENE trial). Contemp Clin Trials 43:10–19. doi: 10.1016/j. cct.2015.05.002. [Epub ahead of print]PubMedCrossRef

Schilling S, Schmid S, Jäger H, Ludwig M, Dietrich H, Toepfl S, Knorr D, Neidhart S, Schieber A, Carle R (2008) Comparative study of pulsed electric field and thermal processing of apple juice with particular consideration of juice quality and enzyme deactivation. J Agric Food Chem 56(12):4545–4554PubMedCrossRef

Sommer CM, Fritz S, Wachter MF, Vollherbst D, Stampfl U, Bellemann N, Gockner T, Mokry T, Gnutzmann D, Schmitz A, Knapp J, Longerich T, Kuhn-Neureuther C, Pereira PL, Kauczor HU, Werner J, Radeleff BA (2013) Irreversible electroporation of the pig kidney with involvement of the renal pelvis: technical aspects, clinical outcome, and three-dimensional CT rendering for assessment of the treatment zone. J Vasc Interv Radiol 24(12):1888–1897PubMedCrossRef

Sugar IP, Neumann E (1984) Stochastic model for electric field-induced membrane pores. Electroporation. Biophys Chem 19(3):211–225PubMedCrossRef

Tacke J (2007) Interventional oncology in urology. Radiologe 47(12):1089–1096PubMedCrossRef

Thomson KR, Cheung W, Ellis SJ et al. (2011) Investigation of the safety of irreversible electroporation in humans. J Vasc Interv Radiol 22:611–621PubMedCrossRef

Toepfl S, Mathys A, Heinz V, Knorr D (2006) Potenzial of high hydrostatic pressure and pulsed electric fields for energy efficient and environmentally friendly food processing. Food Rev Int 22:405–423CrossRef

Tracy CR, Kabbani W, Cadeddu JA (2011) Irreversible electroporation (IRE): a novel method for renal tissue ablation. BJU Int 107(12):1982–1987PubMedCrossRef

Valerio M, Dickinson L, Ali A, Ramachandran N, Donaldson I, Freeman A, Ahmed HU, Emberton M (2014) A prospective development study investigating focal irreversible electroporation in men with localised prostate cancer: Nanoknife Electroporation Ablation Trial (NEAT). Contemp Clin Trials 39(1):57–65PubMedPubMedCentralCrossRef

Wendler JJ, Pech M, Porsch M, Janitzky A, Fischbach F, Buhtz P, Vogler K, Hühne S, Borucki K, Strang C, Mahnkopf D, Ricke J, Liehr UB (2012a) Urinary tract effects after multifocal nonthermal irreversible electroporation of the kidney: acute and chronic monitoring by magnetic resonance imaging, intravenous urography and urinary cytology. Cardiovasc Intervent Radiol 35(4):921–926PubMedCrossRef

Wendler JJ, Pech M, Blaschke S, Porsch M, Janitzky A, Ulrich M, Dudeck O, Ricke J, Liehr UB (2012b) Angiography in the isolated perfused kidney: radiological evaluation of vascular protection in tissue ablation by nonthermal irreversible electroporation. Cardiovasc Intervent Radiol 35(2):383–390PubMedCrossRef

Wendler JJ, Porsch M, Hühne S, Baumunk D, Buhtz P, Fischbach F, Pech M, Mahnkopf D, Kropf S, Roessner A, Ricke J, Schostak M, Liehr UB (2013) Short- and mid-term effects of irreversible electroporation on normal renal tissue: an animal model. Cardiovasc Intervent Radiol 36(2):512–520PubMedCrossRef

Abreu SC, Gill IS (2003) Renal cell carcinoma: modern surgical approach. Curr Opin Urol 13:439–444PubMedCrossRef

Adams JB, Moore RG, Anderson JH, Strandberg JD, Marshall FF, Davoussi LR (1996) High-intensity focused ultrasound ablation of rabbit kidney tumors. J Endourol 10:71–75PubMedCrossRef

Anderson JK, Matsumoto E, Cadeddu JA (2005) Renal radiofrequency ablation: technique and results. Urol Oncology 23:355–360CrossRef

Campbell SC, Krishnamurthi V, Chow G, Hale J, Myles J, Novick AC (1998) Renal cryosurgery: experimental evaluation of treatment parameters. Urology 52:29-33; discussion 33–34CrossRef

Chosy SG, Nakada SY, Lee FT Jr, Warner TF (1998) Monitoring renal cryosurgery: predictors of tissue necrosis in swine. J Urol 159:1370–1374PubMedCrossRef

Chow WH, Devesa SS, Warren JL, Fraumeni JF Jr (1999) Rising incidence of renal cell cancer in the United States. JAMA 281:1628–1631PubMedCrossRef

Finley DS, Beck S, Box G, Chu W, Deane L, Vajgrt DJ et al. (2008) Percutaneous and laparoscopic cryoablation of small renal masses. J Urol 180:492-498; discussion 498PubMedCrossRef

Gervais DA, McGovern FJ, Arellano RS, McDougal WS, Mueller PR (2003) Renal cell carcinoma: clinical experience and technical success with radio-frequency ablation of 42 tumors. Radiology 226:417–424PubMedCrossRef

Gervais DA, Arellano RS, McGovern FJ, McDougal WS, Mueller PR (2005a) Radiofrequency ablation of renal cell carcinoma: part 2, lessons learned with ablation of 100 tumors. AJR 185:72–80PubMedCrossRef

Gervais DA, Arellano RS, Mueller PR (2005b) Percutaneous radiofrequency ablation of renal cell carcinoma. Eur Radiol 15:960–967PubMedCrossRef

Gervais DA, McGovern FJ, Arellano RS, McDougal WS, Mueller PR (2005c) Radiofrequency ablation of renal cell carcinoma: part 1, indications, results, and role in patient management over a 6-year period and ablation of 100 tumors. AJR 185:64–71PubMedCrossRef

Gettman MT, Bishoff JT, Su LM, Chan D, Kavoussi LR, Jarrett TW et al. (2001) Hemostatic laparoscopic partial nephrectomy: initial experience with the radiofrequency coagulation-assisted technique. Urology 58:8–11PubMedCrossRef

Gill IS, Matin SF, Desai MM, Kaouk JH, Steinberg A, Mascha E et al. (2003) Comparative analysis of laparoscopic versus open partial nephrectomy for renal tumors in 200 patients. J Urol 170:64–68PubMedCrossRef

Gill IS, Remer EM, Hasan WA, Strzempkowski B, Spaliviero M, Steinberg AP et al. (2005) Renal cryoablation: outcome at 3 years. J Urol 173:1903–1907PubMedCrossRef

Hacker A, Michel MS, Koehrmann KU (2003) Extracorporeal organotripsy for renal tumours. Curr Opin Urol 13:221–225PubMedCrossRef

Hacker A, Vallo S, Weiss C, Grobholz R, Alken P, Knoll T et al. (2005) Minimally invasive treatment of renal cell carcinoma: comparison of 4 different monopolar radiofrequency devices. Eur Urol 48:584–592PubMedCrossRef

Hacker A, Michel MS, Marlinghaus E, Kohrmann KU, Alken P (2005) Extracorporeally induced ablation of renal tissue by high-intensity focused ultrasound. BJU Int 97:779–785CrossRef

Illing RO, Kennedy JE, Wu F, ter Haar GR, Protheroe AS, Friend PJ et al. (2005) The safety and feasibility of extracorporeal high-intensity focused ultrasound (HIFU) for the treatment of liver and kidney tumours in a Western population. Br J Cancer 93:890–895PubMedPubMedCentralCrossRef

Jacomides L, Ogan K, Watumull L, Cadeddu JA (2003) Laparoscopic application of radio frequency energy enables in situ renal tumor ablation and partial nephrectomy. J Urol 169:49-53; discussion 53PubMedCrossRef

Jang TL, Wang R, Kim SC, Troe T, Pins MR, Nadler RB (2005) Histopathology of human renal tumors after laparoscopic renal cryosurgery. J Urol 173:720–724PubMedCrossRef

Janzen N, Zisman A, Pantuck AJ, Perry K, Schulam P, Belldegrun AS (2002) Minimally invasive ablative approaches in the treatment of renal cell carcinoma. Curr Urol Rep 3:13–20PubMedCrossRef

Johnson DB, Taylor GD, Lotan Y, Sagalowsky AI, Koenemann KS, Cadeddu JA (2003) The effects of radio frequency ablation on renal function and blood pressure. J Urol 170:2234–2236PubMedCrossRef

Johnson DB, Solomon SB, Su LM, Matsumoto ED, Kavoussi LR, Nakada SY et al. (2004) Defining the complications of cryoablation and radio frequency ablation of small renal tumors: a multi-institutional review. J Urol 172:874–877PubMedCrossRef

KlatteT, Mauermann J, Heinz-Peer G, Waldert M, Weibl P, Klingler HC, Remzi M (2011) Perioperative, oncological and functional outcomes of laparoscopic renal cryoablation and open partial nephrectomy: a matched pair analysis. J Endourol 25(6): 991–997

Klingler HC, M Susani (2010) Focal therapy and imaging in prostate and kidney cancer. Renal biopsy protocols pre, post and after focal therapy. J Endourol 24(5):701–705PubMedCrossRef

Klingler HC, Marberger M, Mauermann J, Remzi M, Susani M (2005) »Skipping« is still a problem with radiofrequency ablation of small renal tumours. BJU Int 99:998–1001CrossRef

Klingler HC, Susani M, Seip R, Mauermann J, Sanghvi N, Marberger MJ (2008) A novel approach to energy ablative therapy of small renal tumours: laparoscopic high-intensity focused ultrasound. Eur Urol 53: 810–816PubMedCrossRef

Krambeck AE, Farrell MA, Charboneau JW, Frank I, Zincke H (2005) Intraperitoneal drop metastasis after radiofrequency ablation of pararenal tumor recurrences. Urology 65:79–7

Kunkle DA, Uzzo RG (2008) Cryoablation or radiofrequency ablation of the small renal mass: a meta-analysis. Cancer 113:2671–2680PubMedPubMedCentralCrossRef

Laguna MP, Beemster P, Kumar V, Klingler HC et al. (2009) Perioperative morbidity of laparoscopic cryoablation of small renal masses with ultrathin probes: a European multicentre experience. Eur Urol 56(2):355–361PubMedCrossRef

Lam JS, Shvarts O, Pantuck AJ (2004) Changing concepts in the surgical management of renal cell carcinoma. Eur Urol 45:692–705PubMedCrossRef

Lotan Y, Duchene DA, Cadeddu JA, Sagalowsky AI, Koeneman KS (2004) Changing management of organ-confined renal masses. J Endour 18:263–268CrossRef

Marberger M, Schatzl G, Cranston D, Kennedy JE (2005) Extracorporeal ablation of renal tumours with high-intensity focused ultrasound. BJU Int 95 (Suppl 2):52–55PubMedCrossRef

Matlaga BR, Zagoria RJ, Woodruff RD, Torti FM, Hall MC (2002) Phase II trial of radio frequency ablation of renal cancer: evaluation of the kill zone. J Urol 168:2401–2405PubMedCrossRef

McDougal WS, Gervais DA, McGovern FJ, Mueller PR (2005) Long-term followup of patients with renal cell carcinoma treated with radio frequency ablation with curative intent. J Urol 174:61–63PubMedCrossRef

McGovern FJ, Wood BJ, Goldberg SN, Mueller PR (1999) Radio frequency ablation of renal cell carcinoma via image guided needle electrodes. J Urol 161:599–600PubMedCrossRef

Memarsadeghi M, Schmook T, Remzi M, Weber M, Potscher G, Lammer J et al. (2006) Percutaneous radiofrequency ablation of renal tumors: midterm results in 16 patients. Eur J Radiol 59:183–189PubMedCrossRef

Michaels MJ, Rhee HK, Mourtzinos AP, Summerhayes IC, Silverman ML, Libertino JA (2002) Incomplete renal tumor destruction using radio frequency interstitial ablation. J Urol 168:2406-2409; discussion 2409–2410CrossRef

Murphy DP, Gill IS (2001) Energy-based renal tumor ablation: a review. Semin Urol Oncol 19:133–140PubMed

Novick AC (2004) Laparoscopic and partial nephrectomy. Clin Cancer Res 10:6322S–6327SCrossRef

Novick AC, Derweesh I (2005) Open partial nephrectomy for renal tumours: current status. BJU Int 95(Suppl 2):35–40PubMedCrossRef

Ogan K, Jacomides L, Dolmatch BL, Rivera FJ, Dellaria MF, Josephs SC et al. (2002) Percutaneous radiofrequency ablation of renal tumors: technique, limitations, and morbidity. Urology 60:954–958PubMedCrossRef

Olweny EO, Park SK, Tan YK, Best SL, Trimmer C, Cadeddu JA (2012) Radiofrequency ablation versus partial nephrectomy in patients with solitary clinical T1a renal cell carcinoma: comparable oncologic outcomes at a minimum of 5 years of follow-up. Eur Urol 61:1156–1161PubMedCrossRef

Panumatrassamee K, Kaouk JH, Autorino R, Lenis AT, Laydner H, Isac W et al. (2013) Cryoablation versus minimally invasive partial nephrectomy for small renal masses in the solitary kidney: impact of approach on functional outcomes. J Urol 189:818–822PubMedCrossRef

Psutka SP, Feldman AS, McDougal WS, McGovern FJ, Mueller P, Gervais DA (2013) Long-term oncologic outcomes after radiofrequency ablation for T1 renal cell carcinoma. Eur Urol 63:486–492PubMedCrossRef

Rehman J, Landman J, Lee D, Venkatesh R, Bostwick DG, Sundaram C et al. (2004) Needle-based ablation of renal parenchyma using microwave, cryoablation, impedance- and temperature-based monopolar and bipolar radiofrequency, and liquid and gel chemoablation: laboratory studies and review of the literature. J Endour 18:83–104CrossRef

Remzi M, Ozsoy M, Klingler HC, Susani M, Waldert M, Seitz C et al. (2006) Are small renal tumors harmless? Analysis of histopathological features according to tumors 4 cm or less in diameter. J Urol 176:896–899PubMedCrossRef

Rendon RA, Kachura JR, Sweet JM, Gertner MR, Sherar MD, Robinette M et al. (2002) The uncertainty of radio frequency treatment of renal cell carcinoma: findings at immediate and delayed nephrectomy. J Urol 167:1587–1592PubMedCrossRef

Shingleton WB, Sewell PE (2002a) Percutaneous cryoablation of renal cell carcinoma in a transplanted kidney. BJU Int 90:137–138PubMedCrossRef

Shingleton WB, Sewell PE Jr (2002b) Percutaneous renal cryoablation of renal tumors in patients with von HippelLindau disease. J Urol 167:1268–1270PubMedCrossRef

Shingleton WB, Sewell PE Jr (2003) Cryoablation of renal tumours in patients with solitary kidneys. BJU Int 92: 237–239PubMedCrossRef

Sisul DM, Liss MA, Palazzi KL, Briles K, Mehrazin R, Gold RE et al. (2013) RENAL nephrometry score is associated with complications after renal cryoablation: a multicenter analysis. Urology 81:775–780PubMedCrossRef

Strom KH, Derweesh I, Stroup SP, Malcolm JB, L'Esperance J, Wake RW et al. (2011) Second prize: recurrence rates after percutaneous and laparoscopic renal cryoablation of small renal masses: does the approach make a difference? J Endour 25:371–375CrossRef

Tacke J, Mahnken A, Roggan A, Gunther RW (2004) Multipolar radiofrequency ablation: first clinical results. Rofo 176:324–329PubMedCrossRef

Tan BJ, El-Hakim A, Morgenstern N, Semerdzhiev Y, Smith A, Lee BR (2004) Comparison of laparoscopic saline infused to dry radio frequency ablation of renal tissue: evolution of histological infarct in the porcine model. J Urol 172:2007–2012PubMedCrossRef

Urena R, Mendez F, Woods M, Thomas R, Davis R (2004) Laparoscopic partial nephrectomy of solid renal masses without hilar clamping using a monopolar radio frequency device. J Urol 171:1054–1056PubMedCrossRef

Wagner AA, Solomon SB, Su LM (2005) Treatment of renal tumors with radiofrequency ablation. J Endour 19: 643-652; discussion 652–653

Wah TM, Irving HC, Gregory W, Cartledge J, Joyce AD, Selby PJ (2014) Radiofrequency ablation (RFA) of renal cell carcinoma (RCC): experience in 200 tumours. BJU Int 113: 416–428PubMedCrossRef

Wu F, Wang ZB, Chen WZ, Bai J, Zhu H, Qiao TY (2003) Preliminary experience using high intensity focused ultrasound for the treatment of patients with advanced stage renal malignancy. J Urol 170:2237–2240PubMedCrossRef

Wyler SF, Sulser T, Ruszat R, Weltzien B, Forster TH, Provenzano M et al. (2007) Intermediate-term results of retroperitoneoscopy-assisted cryotherapy for small renal tumours using multiple ultrathin cryoprobes. Eur Urol 51:971–979PubMedCrossRef

Zelkovic PF, Resnick MI (2003) Renal radiofrequency ablation: clinical status 2003. Curr Opin Urol 13:199–202PubMedCrossRef

Zlotta AR, Wildschutz T, Raviv G, Peny MO, van Gansbeke D, Noel JC et al. (1997) Radiofrequency interstitial tumor ablation (RITA) is a possible new modality for treatment of renal cancer: ex vivo and in vivo experience. J Endour 11:251–258CrossRef

Titel: Alternative Verfahren beim Nierenzellkarzinom
verfasst von: Dr. med. B. Friebe
Dr. med. T. Bretschneider
Prof. Dr. med. J. Ricke
Priv.-Doz. Dr. med. habil. U.-B. Liehr
Dr. med. J. J. Wendler
Prof. Dr. med. H. C. Klingler
Prof. Dr. med. M. Susani
Dr. med. S. Sevcenco
Verlag: Springer Berlin Heidelberg
Buch: Alternative operative Therapien in der Uroonkologie
Print ISBN: 978-3-662-44419-1

Electronic ISBN: 978-3-662-44420-7

Copyright-Jahr: 2016
DOI: https://doi.org/10.1007/978-3-662-44420-7_2

Neu im Fachgebiet Urologie

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

Stufenschema weist Prostatakarzinom zuverlässig nach

22.04.2024 Prostatakarzinom Nachrichten

Erst PSA-Test, dann Kallikrein-Score, schließlich MRT und Biopsie – ein vierstufiges Screening-Schema kann die Zahl der unnötigen Prostatabiopsien erheblich reduzieren: Die Hälfte der Männer, die in einer finnischen Studie eine Biopsie benötigten, hatte einen hochgradigen Tumor.

Harnwegsinfektprophylaxe: Es geht auch ohne Antibiotika

20.04.2024 EAU 2024 Kongressbericht

Beim chronischen Harnwegsinfekt bei Frauen wird bisher meist eine Antibiotikaprophylaxe eingesetzt. Angesichts der zunehmenden Antibiotikaresistenz erweist sich das Antiseptikum Methenamin-Hippurat als vielversprechende Alternative, so die Auswertung einer randomisierten kontrollierten Studie.

Update Urologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen